Common Genetic Variation and Breast Cancer Risk—Past, Present, and Future

Peto, 2000, High constant incidence in twins and other relatives of women with breast cancer, Nat Genet, 26, 411, 10.1038/82533

Colditz, 1993, Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study, JAMA, 270, 338, 10.1001/jama.1993.03510030062035

Miki, 1994, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, 266, 66, 10.1126/science.7545954

Wooster, 1995, Identification of the breast cancer susceptibility gene BRCA2, Nature, 378, 789, 10.1038/378789a0

Rahman, 2007, PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene, Nat Genet, 39, 165, 10.1038/ng1959

Renwick, 2006, ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles, Nat Genet, 38, 873, 10.1038/ng1837

Meijers-Heijboer, 2002, Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations, Nat Genet, 31, 55, 10.1038/ng879

Breast Cancer Association Consortium, 2006, Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium, J Natl Cancer Inst, 98, 1382, 10.1093/jnci/djj374

Cox, 2007, A common coding variant in CASP8 is associated with breast cancer risk, Nat Genet, 39, 352, 10.1038/ng1981

Couch, 2016, Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer, Nat Commun, 7, 11375, 10.1038/ncomms11375

Hunter, 2007, A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer, Nat Genet, 39, 870, 10.1038/ng2075

Easton, 2007, Genome-wide association study identifies novel breast cancer susceptibility loci, Nature, 447, 1087, 10.1038/nature05887

Stacey, 2008, Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer, Nat Genet, 40, 703, 10.1038/ng.131

Garcia-Closas, 2008, Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics, PLoS Genet, 4, e1000054, 10.1371/journal.pgen.1000054

Antoniou, 2008, Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers, Am J Hum Genet, 82, 937, 10.1016/j.ajhg.2008.02.008

Ahmed, 2009, Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2, Nat Genet, 41, 585, 10.1038/ng.354

Zheng, 2009, Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1, Nat Genet, 41, 324, 10.1038/ng.318

Mavaddat, 2010, Genetic susceptibility to breast cancer, Mol Oncol, 4, 174, 10.1016/j.molonc.2010.04.011

Ghoussaini, 2012, Genome-wide association analysis identifies three new breast cancer susceptibility loci, Nat Genet, 44, 312, 10.1038/ng.1049

Turnbull, 2010, Genome-wide association study identifies five new breast cancer susceptibility loci, Nat Genet, 42, 504, 10.1038/ng.586

Fletcher, 2011, Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study, J Natl Cancer Inst, 103, 425, 10.1093/jnci/djq563

Michailidou, 2013, Large-scale genotyping identifies 41 new loci associated with breast cancer risk, Nat Genet, 45, 353, 10.1038/ng.2563

Michailidou, 2015, Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer, Nat Genet, 47, 373, 10.1038/ng.3242

Michailidou, 2017, Association analysis identifies 65 new breast cancer risk loci, Nature, 551, 92, 10.1038/nature24284

Milne, 2017, Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer, Nat Genet, 49, 1767, 10.1038/ng.3785

Chenevix-Trench, 2007, An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA), Breast Cancer Res, 9, 104, 10.1186/bcr1670

Antoniou, 2007, RAD51 135G→C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies, Am J Hum Genet, 81, 1186, 10.1086/522611

Antoniou, 2009, Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers, Hum Mol Genet, 18, 4442, 10.1093/hmg/ddp372

Antoniou, 2011, Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, Hum Mol Genet, 20, 3304, 10.1093/hmg/ddr226

Antoniou, 2012, Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers, Breast Cancer Res, 14, R33, 10.1186/bcr3121

Osorio, 2008, An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers, Br J Cancer, 99, 974, 10.1038/sj.bjc.6604624

Sinilnikova, 2009, The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers, Br J Cancer, 101, 1456, 10.1038/sj.bjc.6605279

Osorio, 2009, Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA), Br J Cancer, 101, 2048, 10.1038/sj.bjc.6605416

Engel, 2010, Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers, Cancer Epidemiol Biomarkers Prev, 19, 2859, 10.1158/1055-9965.EPI-10-0517

Osorio, 2011, Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2, Br J Cancer, 104, 1356, 10.1038/bjc.2011.91

Ding, 2012, A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers, Cancer Epidemiol Biomarkers Prev, 21, 1362, 10.1158/1055-9965.EPI-12-0229

Wang, 2010, Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers, Hum Mol Genet, 19, 2886, 10.1093/hmg/ddq174

Stevens, 2012, Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers, Breast Cancer Res Treat, 136, 295, 10.1007/s10549-012-2255-6

Osorio, 2014, DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers, PLoS Genet, 10, e1004256, 10.1371/journal.pgen.1004256

Antoniou, 2010, A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population, Nat Genet, 42, 885, 10.1038/ng.669

Stevens, 2012, 19p13.1 is a triple-negative-specific breast cancer susceptibility locus, Cancer Res, 72, 1795, 10.1158/0008-5472.CAN-11-3364

Couch, 2013, Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk, PLoS Genet, 9, e1003212, 10.1371/journal.pgen.1003212

Mavaddat, 2012, Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), Cancer Epidemiol Biomarkers Prev, 21, 134, 10.1158/1055-9965.EPI-11-0775

Mulligan, 2011, Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2, Breast Cancer Res, 13, R110, 10.1186/bcr3052

Kuchenbaecker, 2014, Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers, Breast Cancer Res, 16, 3416, 10.1186/s13058-014-0492-9

Stacey, 2007, Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer, Nat Genet, 39, 865, 10.1038/ng2064

Haiman, 2011, A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer, Nat Genet, 43, 1210, 10.1038/ng.985

Garcia-Closas, 2013, Genome-wide association studies identify four ER negative-specific breast cancer risk loci, Nat Genet, 45, 392, 10.1038/ng.2561

Stevens, 2011, Common breast cancer susceptibility loci are associated with triple-negative breast cancer, Cancer Res, 71, 6240, 10.1158/0008-5472.CAN-11-1266

Purrington, 2014, Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer, Carcinogenesis, 35, 1012, 10.1093/carcin/bgt404

Pfaff, 2001, Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium, Am J Hum Genet, 68, 198, 10.1086/316935

Chu, 2002, Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups, Breast Cancer Res Treat, 74, 199, 10.1023/A:1016361932220

Newman, 2017, Health disparities and triple-negative breast cancer in African American women: a review, JAMA Surg, 152, 485, 10.1001/jamasurg.2017.0005

Murphy, 2017, A functionally significant SNP in TP53 and breast cancer risk in African-American women, NPJ Breast Cancer, 3, 5, 10.1038/s41523-017-0007-9

Ruiz-Narvaez, 2013, Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women, Carcinogenesis, 34, 287, 10.1093/carcin/bgs334

Ruiz-Narvaez, 2016, Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium, NPJ Breast Cancer, 2, 16034, 10.1038/npjbcancer.2016.34

Ruiz-Narvaez, 2016, Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium, Breast Cancer Res Treat, 155, 355, 10.1007/s10549-015-3672-0

Yao, 2016, Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium, Int J Cancer, 138, 2118, 10.1002/ijc.29954

Feng, 2014, A comprehensive examination of breast cancer risk loci in African American women, Hum Mol Genet, 23, 5518, 10.1093/hmg/ddu252

Long, 2013, Evaluating genome-wide association study-identified breast cancer risk variants in African-American women, PLoS One, 8, e58350, 10.1371/journal.pone.0058350

Song, 2013, A genome-wide scan for breast cancer risk haplotypes among African American women, PLoS One, 8, e57298, 10.1371/journal.pone.0057298

Palmer, 2013, Genetic susceptibility loci for subtypes of breast cancer in an African American population, Cancer Epidemiol Biomarkers Prev, 22, 127, 10.1158/1055-9965.EPI-12-0769

Chen, 2011, Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans, Hum Mol Genet, 20, 4491, 10.1093/hmg/ddr367

Hutter, 2011, Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study, Cancer Epidemiol Biomarkers Prev, 20, 1950, 10.1158/1055-9965.EPI-11-0524

Zhang, 2016, Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium, Carcinogenesis, 37, 951, 10.1093/carcin/bgw077

Huo, 2012, Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry, Carcinogenesis, 33, 835, 10.1093/carcin/bgs093

Palmer, 2014, A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium, Cancer Causes Control, 25, 309, 10.1007/s10552-013-0332-8

Chen, 2013, A genome-wide association study of breast cancer in women of African ancestry, Hum Genet, 132, 39, 10.1007/s00439-012-1214-y

Huo, 2016, Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer, Hum Mol Genet, 25, 4835

Ruiz-Narvaez, 2016, Admixture mapping of African-American women in the AMBER consortium identifies new loci for breast cancer and estrogen-receptor subtypes, Front Genet, 7, 170, 10.3389/fgene.2016.00170

Zheng, 2013, Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls, Hum Mol Genet, 22, 2539, 10.1093/hmg/ddt089

Cai, 2014, Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1, Nat Genet, 46, 886, 10.1038/ng.3041

Gail, 2008, Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk, J Natl Cancer Inst, 100, 1037, 10.1093/jnci/djn180

Mavaddat, 2015, Prediction of breast cancer risk based on profiling with common genetic variants, J Natl Cancer Inst, 107, djv036, 10.1093/jnci/djv036

Vachon, 2015, The contributions of breast density and common genetic variation to breast cancer risk, J Natl Cancer Inst, 107, dju397, 10.1093/jnci/dju397

Rudolph, Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium, Int J Epidemiol

CHEK2 Breast Cancer Case-Control Consortium, 2004, CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies, Am J Hum Genet, 74, 1175, 10.1086/421251

Weischer, 2008, CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls, J Clin Oncol, 26, 542, 10.1200/JCO.2007.12.5922

Muranen, 2017, Genetic modifiers of CHEK2*1100delC-associated breast cancer risk, Genet Med, 19, 599, 10.1038/gim.2016.147

Kuchenbaecker, 2017, Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers, J Natl Cancer Inst, 109, djw302, 10.1093/jnci/djw302

Dite, 2016, Breast cancer risk prediction using clinical models and 77 independent risk-associated SNPs for women aged under 50 years: Australian Breast Cancer Family Registry, Cancer Epidemiol Biomarkers Prev, 25, 359, 10.1158/1055-9965.EPI-15-0838

Hughes, 2017, Development and validation of a residual risk score to predict breast cancer risk in unaffected women negative for mutations on a multi-gene hereditary cancer panel, J Clin Oncol, 35, 10.1200/JCO.2017.35.15_suppl.1579

Shieh, 2017, Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial, J Natl Cancer Inst, 109, djw290, 10.1093/jnci/djw290

Varghese, 2012, Mammographic breast density and breast cancer: evidence of a shared genetic basis, Cancer Res, 72, 1478, 10.1158/0008-5472.CAN-11-3295

Stone, 2015, Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures, Cancer Res, 75, 2457, 10.1158/0008-5472.CAN-14-2012

Lindstrom, 2014, Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk, Nat Commun, 5, 5303, 10.1038/ncomms6303

Rudolph, 2016, Gene-environment interaction and risk of breast cancer, Br J Cancer, 114, 125, 10.1038/bjc.2015.439

Travis, 2010, Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study, Lancet, 375, 2143, 10.1016/S0140-6736(10)60636-8

Nickels, 2013, Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors, PLoS Genet, 9, e1003284, 10.1371/journal.pgen.1003284

Schoeps, 2014, Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions, Genet Epidemiol, 38, 84, 10.1002/gepi.21771

Edwards, 2013, Beyond GWASs: illuminating the dark road from association to function, Am J Hum Genet, 93, 779, 10.1016/j.ajhg.2013.10.012

Bojesen, 2013, Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer, Nat Genet, 45, 371, 10.1038/ng.2566

Dunning, 2016, Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170, Nat Genet, 48, 374, 10.1038/ng.3521

Ghoussaini, 2016, Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen-receptor-positive breast cancer through FGF10 and MRPS30 regulation, Am J Hum Genet, 99, 903, 10.1016/j.ajhg.2016.07.017

Lonsdale, 2013, The Genotype-Tissue Expression (GTEx) project, Nat Genet, 45, 580, 10.1038/ng.2653

Hoffman, 2017, Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk, PLoS Genet, 13, e1006690, 10.1371/journal.pgen.1006690

French, 2013, Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers, Am J Hum Genet, 92, 489, 10.1016/j.ajhg.2013.01.002

Betts, 2017, Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage, Am J Hum Genet, 101, 255, 10.1016/j.ajhg.2017.07.007

MacPherson, 2004, Association of a common variant of the CASP8 gene with reduced risk of breast cancer, J Natl Cancer Inst, 96, 1866, 10.1093/jnci/dji001

Lin, 2015, Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk, Hum Mol Genet, 24, 285, 10.1093/hmg/ddu431

Udler, 2010, Fine scale mapping of the breast cancer 16q12 locus, Hum Mol Genet, 19, 2507, 10.1093/hmg/ddq122

Meyer, 2013, Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1, Am J Hum Genet, 93, 1046, 10.1016/j.ajhg.2013.10.026

Ghoussaini, 2014, Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation, Nat Commun, 4, 4999, 10.1038/ncomms5999

Wyszynski, 2016, An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression, Hum Mol Genet, 25, 3863, 10.1093/hmg/ddw223

Darabi, 2016, Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs), Sci Rep, 6, 32512, 10.1038/srep32512

Hall, 2009, The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations, Biochem Soc Trans, 37, 527, 10.1042/BST0370527

Thomas, 2009, A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1), Nat Genet, 41, 579, 10.1038/ng.353

Lawrenson, 2016, Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus, Nat Commun, 7, 12675, 10.1038/ncomms12675

Cai, 2011, Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium, Hum Mol Genet, 20, 4991, 10.1093/hmg/ddr405

Darabi, 2015, Polymorphisms in a putative enhancer at the 10q21.2 breast cancer risk locus regulate NRBF2 expression, Am J Hum Genet, 97, 22, 10.1016/j.ajhg.2015.05.002

Orr, 2015, Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2, Hum Mol Genet, 24, 2966, 10.1093/hmg/ddv035

Long, 2012, Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer, PLoS Genet, 8, e1002532, 10.1371/journal.pgen.1002532

Siddiq, 2012, A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11, Hum Mol Genet, 21, 5373, 10.1093/hmg/dds381

Gaudet, 2013, Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk, PLoS Genet, 9, e1003173, 10.1371/journal.pgen.1003173

Milne, 2014, Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium, Hum Mol Genet, 23, 6096, 10.1093/hmg/ddu311

Sawyer, 2014, Genetic predisposition to in situ and invasive lobular carcinoma of the breast, PLoS Genet, 10, e1004285, 10.1371/journal.pgen.1004285